Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Sanofi-Aventis S.A. (NQ: SNY)
45.32   -0.62 (-1.35%)
Official Closing Price  /  Updated: 5:14 PM EDT, Oct 22, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,290,903
Open 45.69
Bid (Size) 42.05 (1)
Ask (Size) 45.35 (31)
Prev. Close 45.94
Today's Range 45.19 - 45.93
52wk Range 40.00 - 47.11
Shares Outstanding N/A
Dividend Yield N/A
Performance
YTD
+5.74%
+5.74%
1 Month
-1.93%
-1.93%
3 Month
+7.44%
+7.44%
6 Month
+9.60%
+9.60%
1 Year
+5.74%
+5.74%
Top News
More News
Sanofi to conduct precautionary voluntary recall of Zantac OTC in U.S. and Canada
As a precautionary measure, Sanofi will conduct a voluntary recall of Zantac OTC (over-the-counter) in the U.S. and Canada. This recall is being taken due to possible contamination with a nitrosamine... Read More
from PR Newswire
Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing
- One of the first digital manufacturing facilities in the world to use continuous, intensified biologics production technology Read More
from PR Newswire
More News
Read More
New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer
from PR Newswire
Sanofi Canada receives Gold-Level Parity Certification
from PR Newswire
Hagens Berman: Law Firm Taking on Drug Makers in Zantac Class Action Condemns FDA’s “Reckless” Cover-up of Ranitidine Carcinogen
from Business Wire News Releases
14 Healthcare Stocks Moving In Thursday's Pre-Market Session
category BNGO , HEPA , Movers , and 22 more.
from Benzinga
Innate Pharma IPO: What You Need To Know
category IPOs , Trading Ideas , Benzinga , and 7 more.
from Benzinga
Is Amicus Therapeutics a Buy?
category Market News , SNY , FOLD
from Motley Fool
Here's Why Dermira Stock Is Rocketing Higher Today
category SNY , RHHBY , DERM , and 2 more.
from Motley Fool
BioNTech IPO: What You Need To Know
category Benzinga , IPOs , BAYRY , and 10 more.
from Benzinga
Big Pharma Has Mad Love For These 2 Biotechs
category TAK , RCKT , NVS , and 9 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.